Skip to content

To evaluate the effect of Palashaadi varti on abnormal vaginal discharges.

Evaluation of the Effect of Palashadi Varti in the Management of Shweta Pradar (Abnormal Vaginal Discharge) on Clinical & Microbiological Parameters

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052519
Enrollment
200
Registered
2023-05-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R688- Other general symptoms and signs

Interventions

None listed

Sponsors

RGGPG Ayurvedic College and Hospital
Lead Sponsor
HOD Department of Prasuti Tantra avum Stree Roga
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient willing for the trial and ready to consent. 2. Married female patients/sexually active patients. 3. Patient complaining Shewtapradar(Abnormal Vaginal Discharge) as a major symptom. 4. Women of Reproductive Age Group between 20 to 45 years of age.

Exclusion criteria

Exclusion criteria: 1.Unmarried women 2.Pregnancy 3.Lactating 4.Menopausal 5.Certain Gynecological Pathologies like CA cervix , fibroid polyp etc. 6.HIV positive patients. 7.Diabetic 8. Severely Anemic patients.

Design outcomes

Primary

MeasureTime frame
Overall improvement in vaginal discharge, congestion, vaginal itching and cervical erosionsTimepoint: 14 days

Secondary

MeasureTime frame
The results of antibacterial study to prove the effectiveness of trial drug on specific bacteriaTimepoint: 1 and half year

Countries

India

Contacts

Public ContactDr Akshita

RGGPG Ayurvedic College and Hospital

skbhardwaj73@gmail.com9418499799

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026